Close Menu
PNN DigitalPNN Digital
    Facebook X (Twitter) Instagram
    PNN DigitalPNN Digital
    • Business
    • National
    • Entertainment
    • Lifestyle
    • Education
    • Press Release
    • Submit Your PR
    PNN DigitalPNN Digital
    Home - Business - Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets
    Business

    Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets

    PNN Online DeskBy PNN Online DeskOctober 9, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Hyderabad (Telangana) [India], October 09: Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti® Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, of Otsuka Pharmaceutical Co., Ltd. Optimus Pharma’s approval for its Abbreviated New Drug Application (ANDA) BREXPIPRAZOLE Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, was received on October 8th, 2021. BREXPIPRAZOLE will be manufactured at Optimus Pharma’s Pashmylaram USFDA accredited facility in India.

    BREXPIPRAZOLE Tablets (RLD: Rexulti® Tablets) had estimated annual sales of USD 1258 million in the U.S. (IQVIA MAT July 2021).

    BREXPIPRAZOLE has a favourable antipsychotic profile in terms of improvement of cognitive performance and sleep patterns, as well as effects on affective states and potential to treat core symptoms in schizophrenia and major depressive disorder, including cognitive deficits with a low risk of adverse effects (extrapyramidal symptoms, metabolic complications, weight gain, akathisia potential) that are commonly encountered with other typical and second-generation antipsychotic drugs. From the studies done so far, it can be concluded that BREXPIPRAZOLE can be effective monotherapy for schizophrenia and as an adjunct to other antidepressant medications in major depressive disorder.

    About Optimus Pharma

    Optimus was established in the year 2004 as a custom synthesis laboratory by a team of techno-commercial experts. It is one of the fastest-growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Over the last decade, we have been certified and audited by reputed Global Regulatory Agencies like USFDA, WHO, COFEPRIS, EMA, KFDA and AFM from PMDA Japan. Optimus Pharma is a vertically integrated pharmaceutical company engaged in the manufacturing of Solid Oral and semisolid formulations. We have successfully integrated our API and Formulation R&D teams, with the IP and Regulatory Affairs team in order to ensure a dynamic product portfolio. We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly products of the highest quality.

    Optimus Pharma Optimus Pharma US FDA
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    PNN Online Desk
    • Website

    Related Posts

    1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event

    August 4, 2025

    18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination

    August 4, 2025

    Driving Sustainability in Food Supply Chains: A Global Leader’s Journey from India to the U.S.

    August 4, 2025
    Add A Comment

    Comments are closed.

    Recent Posts
    • 1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event
    • 18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination
    • Driving Sustainability in Food Supply Chains: A Global Leader’s Journey from India to the U.S.
    • Wah! Puchka Wah! Litti Raises USD 230k from Wow Momo Founder Sagar Daryani, and other Global Angel Investors
    • GTF Technologies: The Agency That Quietly Reimagined Real Estate Marketing in India

    1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event

    August 4, 2025

    18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination

    August 4, 2025

    Driving Sustainability in Food Supply Chains: A Global Leader’s Journey from India to the U.S.

    August 4, 2025

    Wah! Puchka Wah! Litti Raises USD 230k from Wow Momo Founder Sagar Daryani, and other Global Angel Investors

    August 4, 2025

    GTF Technologies: The Agency That Quietly Reimagined Real Estate Marketing in India

    August 4, 2025

    Kolkata’s Quiet Force Propels India to Global Space Leadership: Heritage Alumnus Subhradip Ghosh Orchestrates NISAR Mission’s Historic Launch

    August 4, 2025
    PNN Digital
    2025 © pnn.digital

    Type above and press Enter to search. Press Esc to cancel.